SRRKScholar Rock Holding Corporation
48.05USD-2.70%Mkt Cap: 5.72B USDP/E: Last update: 2026-06-01

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on improving the lives of children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. The…

Indicators:|

Key Statistics

Company
Market Cap5.72B USD
Enterprise Value5.63B USD
Revenue (TTM)
Gross Profit-211.58M USD
Net Income (TTM)-377.94M USD
Revenue/Share
Last Price48.05 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees289
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS80706P1030
Valuation
P/E (Trailing)
P/E (Forward)-20.50
PEG
EV/EBITDA-13.81
EV/Revenue
P/S
P/B21.79
EPS (TTM)-3.45
EPS (Forward)-2.41
52W Range
27.0784% of range52.19
52W High52.19 USD
52W Low27.07 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-153.95%
ROA-93.49%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-300.04M USD
CapEx (TTM)602.00K USD
FCF Margin
FCF Yield-3.00%
Net Debt-274.27M USD
Net Debt/EBITDA0.67
Balance Sheet
Debt/Equity0.44
Current Ratio8.64
Quick Ratio8.41
Book Value/Sh2.263 USD
Cash/Share4.005 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)59.00 USD
Target Range48.00 USD70.00 USD
# Analysts16
Ownership
Shares Out.119.83M
Float91.86M
Insiders0.76%
Institutions116.14%
Short Interest
Short Ratio11.5d
Short % Float16.38%
Short % Out.13.07%
Shares Short15.66M
Short (prev mo.)14.81M
Technical
SMA 5047.80 (+0.5%)
SMA 20041.26 (+16.5%)
Beta0.71
S&P 52W Chg27.70%
Avg Vol (30d)1.13M
Avg Vol (10d)1.24M
Technical Indicators
RSI (14)53.4
MACD0.6463
MACD Signal0.5276
MACD Hist.+0.1188
BB Upper51.77 USD
BB Middle48.56 USD
BB Lower45.35 USD
BB Width13.21%
ATR (14)2.169 USD
Vol Ratio (20d)0.38x